Company intelligence / Profile preview

Dryox Health

Barcelona, Catalonia, Spaindryoxhealth.com ↗

Ownership: Private
Development stage: Commercial

Overview

Dryox Health is conducting a Phase II clinical trial to demonstrate the safety and efficacy of its lead product, VICTORHY, in treating severe palmar primary hyperhidrosis. The company focuses on drug repurposing to address unmet needs in cholinergic-related diseases

Therapeutic areas: DermatologyOphthalmologyNeurology
Modalities: Small molecule
Industry: Biotech

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed; seeking funding from public research institutions and European programs as well as private investors

Beyond the preview

Go deeper on Dryox Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dryox Health.

Explore the full profile